16 parallel-computing-numerical-methods-"Prof" positions at Nature Careers in Australia
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
% superannuation. Fixed term, full-time position available for five yearsincluding a competitive research support package. We invite applications to join the Computational Systems Oncology Program at SAiGENCI as a
-
(including patent-relevant work) What will you bring? A PhD in bioinformatics, computational biology or a parallel field such as immunology with demonstrated experience in bioinformatics An understanding
-
of Medical Research. The laboratory specialises in single-cell RNA sequencing, spatial transcriptomics and computational pipelines applied to patient biospecimens to understand the complexity of intestinal
-
fundamental research and the pharmaceutical and biotechnology industries. The research program is co-funded by the Australian Research Council and the Sydney- and US-based biotech company INSAMO and the
-
atherosclerosis. A range of biotechnological methods are used, including recombinant protein design/production, cell culture, flow cytometry, generation of functionalised nanoparticles/liposomes/microbubbles, flow
-
program under the mentorship of the laboratory group leader. Formulating the research question, performing the laboratory research, analysing the data, preparing and submitting research manuscripts
-
) GRADE 7, £39,355 - £45,413 pa Fixed-term Ref: 095593 A Research Fellow position is available in the group of Professor M. J. Rosseinsky OBE FRS to work in a team of computer scientists and materials
-
external experimentalist. You should have expertise in at least one of the following areas (i) Non-adiabatic chemical dynamics, (ii) Physics of charge transport in the solid state, (iii) QM/MM methods, (iv
-
other research institutes, QIMR Berghofer is home to more than 600 scientists, students and non-research staff. Population Health Program: The Population Health Program includes 12 research groups working
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural